FTSE 100

FTSE 100 Market news covers the latest developments for the FTSE 100 Index, which tracks the 100 most highly capitalised blue‑chip companies listed on the London Stock Exchange.

This category includes updates on company admissions and delistings, quarterly and annual results, mergers and acquisitions, board appointments and departures, regulatory news and policy changes.

Diploma PLC 24.2% potential upside indicated by Berenberg Bank

Diploma PLC with ticker (LON:DPLM) now has a potential upside of 24.2% according to Berenberg Bank.Berenberg Bank set a target price of 4,400 GBX for the company, which when compared..

Rentokil Initial plc 29.0% potential upside indicated by RBC Capital Markets

Rentokil Initial plc with ticker (LON:RTO) now has a potential upside of 29.0% according to RBC Capital Markets.RBC Capital Markets set a target price of 590 GBX for the company,..

Relx PLC 6.8% potential upside indicated by Berenberg Bank

Relx PLC with ticker (LON:REL) now has a potential upside of 6.8% according to Berenberg Bank.Berenberg Bank set a target price of 3,500 GBX for the company, which when compared..

Ashtead Group plc -9.6% potential downside indicated by RBC Capital Markets

Ashtead Group plc with ticker (LON:AHT) now has a potential downside of -9.6% according to RBC Capital Markets.RBC Capital Markets set a target price of 5,100 GBX for the company,..

International Consolidated Airlns Grp SA 27.1% potential upside indicated by RBC Capital Markets

International Consolidated Airlns Grp SA with ticker (LON:IAG) now has a potential upside of 27.1% according to RBC Capital Markets.RBC Capital Markets set a target price of 220 GBX for..

Entain PLC 45.9% potential upside indicated by Berenberg Bank

Entain PLC with ticker (LON:ENT) now has a potential upside of 45.9% according to Berenberg Bank.Berenberg Bank set a target price of 1,140 GBX for the company, which when compared..

AstraZeneca’s Imfinzi shows positive results in Phase III trial for small cell lung cancer

AstraZeneca's Imfinzi shows significant improvement in overall survival and progression-free survival in limited-stage small cell lung cancer patients after chemoradiotherapy. Exciting breakthrough in treatment...

Entain plc Chairman Barry Gibson to retire, Stella David to succeed

Entain plc announces Barry Gibson's retirement as Chair, with Stella David set to take over. Stella, current interim CEO, brings extensive experience to the role...

LondonMetric Property Additional Listing in Relation to Dividend

LondonMetric Property Plc (LON:LMP) announces third quarterly dividend. Find out more about the dividend scheme and upcoming Admission details...

HSBC Holdings completes sale of HSBC Bank Canada to RBC

HSBC Holdings plc (LON:HSBA) completes sale of HSBC Bank Canada to RBC, unlocking value and planning special dividend for shareholders in 2024...

AstraZeneca’s Voydeya approved in the US as add-on therapy for PNH patients with EVH

AstraZeneca's Voydeya (danicopan) has been approved in the US as add-on therapy for PNH patients with EVH. Find out more about this breakthrough treatment...

Marathon Oil Corporation – Consensus ‘buy’ rating and 15.7% Upside Potential

Marathon Oil Corporation which can be found using ticker (MRO) have now 21 market analysts covering the stock. The analyst consensus now points to a rating of ‘buy’. The range..

F&C Investment Trust plc appoints Richard Robinson as independent Non-Executive Director

Richard Robinson will be joining the Board of F&C Investment Trust plc as an independent Non-Executive Director from 3 May 2024, replacing Tom Joy...

Anglo American Plc’s Kumba Iron Ore achieves IRMA 75 level of performance

Anglo American plc notes Kumba Iron Ore's achievement of IRMA 75 level at Sishen and Kolomela mines, showcasing commitment to responsible mining...

Diploma Plc to acquire specialty fasteners business, Peerless Aerospace Fastener

Diploma PLC has announced the acquisition of Peerless Aerospace Fastener LLC for ca. £236m. Learn about the strategic fit and growth potential of this deal...

Ocado Group reports strong Q1 2024 performance with 10.6% revenue growth

Ocado Retail Ltd, a joint venture between Ocado Group plc and Marks & Spencer Group plc, reports strong Q1 2024 performance with revenue growth and increased market share. CEO Hannah..

Smiths Group Plc reports +3.9% organic revenue growth, +16.5% order growth

Smiths Group PLC (LON:SMIN) reports strong half-year results with organic revenue growth and double-digit order growth, underpinning future growth and performance improvements...

AstraZeneca Ultomiris granted approval in US for treatment of adults with neuromyelitis optica spectrum disorder

Ultomiris, the first long-acting C5 complement inhibitor, shows promise in reducing relapse risk for AQP4 Ab+ NMOSD patients. Learn more here...

Ashtead Group plc -8.2% potential downside indicated by RBC Capital Markets

Ashtead Group plc with ticker (LON:AHT) now has a potential downside of -8.2% according to RBC Capital Markets.RBC Capital Markets set a target price of 5,100 GBX for the company,..

IMI plc 6.6% potential upside indicated by Berenberg Bank

IMI plc with ticker (LON:IMI) now has a potential upside of 6.6% according to Berenberg Bank.Berenberg Bank set a target price of 1,950 GBX for the company, which when compared..

Search

Funds

FTSE 100

AstraZeneca’s Imfinzi shows positive results in Phase III trial for small cell lung cancer

AstraZeneca's Imfinzi shows significant improvement in overall survival and progression-free survival in limited-stage small cell lung cancer patients after chemoradiotherapy. Exciting breakthrough in treatment...

Entain plc Chairman Barry Gibson to retire, Stella David to succeed

Entain plc announces Barry Gibson's retirement as Chair, with Stella David set to take over. Stella, current interim CEO, brings extensive experience to the role...

LondonMetric Property Additional Listing in Relation to Dividend

LondonMetric Property Plc (LON:LMP) announces third quarterly dividend. Find out more about the dividend scheme and upcoming Admission details...

HSBC Holdings completes sale of HSBC Bank Canada to RBC

HSBC Holdings plc (LON:HSBA) completes sale of HSBC Bank Canada to RBC, unlocking value and planning special dividend for shareholders in 2024...

AstraZeneca’s Voydeya approved in the US as add-on therapy for PNH patients with EVH

AstraZeneca's Voydeya (danicopan) has been approved in the US as add-on therapy for PNH patients with EVH. Find out more about this breakthrough treatment...

F&C Investment Trust plc appoints Richard Robinson as independent Non-Executive Director

Richard Robinson will be joining the Board of F&C Investment Trust plc as an independent Non-Executive Director from 3 May 2024, replacing Tom Joy...

Anglo American Plc’s Kumba Iron Ore achieves IRMA 75 level of performance

Anglo American plc notes Kumba Iron Ore's achievement of IRMA 75 level at Sishen and Kolomela mines, showcasing commitment to responsible mining...

Diploma Plc to acquire specialty fasteners business, Peerless Aerospace Fastener

Diploma PLC has announced the acquisition of Peerless Aerospace Fastener LLC for ca. £236m. Learn about the strategic fit and growth potential of this deal...

Ocado Group reports strong Q1 2024 performance with 10.6% revenue growth

Ocado Retail Ltd, a joint venture between Ocado Group plc and Marks & Spencer Group plc, reports strong Q1 2024 performance with revenue growth and increased market share. CEO Hannah Gibson highlights strategic improvements for customers...

Smiths Group Plc reports +3.9% organic revenue growth, +16.5% order growth

Smiths Group PLC (LON:SMIN) reports strong half-year results with organic revenue growth and double-digit order growth, underpinning future growth and performance improvements...

AstraZeneca Ultomiris granted approval in US for treatment of adults with neuromyelitis optica spectrum disorder

Ultomiris, the first long-acting C5 complement inhibitor, shows promise in reducing relapse risk for AQP4 Ab+ NMOSD patients. Learn more here...
Search

Funds

FTSE 100

FTSE 100

Funds